RE
NASDAQ · RETA
Reata Pharmaceuticals, Inc.
Healthcare · Biotechnology
$172.36
Up+$0.04 (+0.02%)
Updated Sep 12, 2026, 6:39 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.57B
- P/E ratio
- -20.07
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.91M
- Avg. volume
- 969.33K
Price performance
RETA price history
1M range · 0 trading sessions · Daily adjusted prices
RETA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest RETA news
The latest Smart Investors Daily articles mentioning RETA.
Stock researchResearch & News · SEC Filings
Loading stock research…
